Several angiogenesis-related genes were upregulated within glioma RCCS cultures in comparison to monolayer cultures, including components of the FGF and TGFβ signaling pathways, suggesting that these factors are mediators of VM that may be targeted therapeutically. The gene discussed is TGFB1; the disease is glioma.